Genhong Cheng

Title(s)Professor, MIMG
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
    NIH R01AI158154Aug 1, 2020 - Jul 31, 2025
    Role: Principal Investigator
    Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV
    NIH R01AI140718May 2, 2018 - Apr 30, 2023
    Role: Co-Principal Investigator
    IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation
    NIH R21AI092525Jan 1, 2011 - Dec 31, 2013
    Role: Principal Investigator
    Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
    NIH R01AI078389Jul 1, 2009 - Jun 30, 2015
    Role: Principal Investigator
    Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
    NIH R56AI078389Sep 17, 2008 - Jun 30, 2009
    Role: Principal Investigator
    Regulation of Type 2 NF-kappaB Activation and Inflammation
    NIH R01GM078607Jul 1, 2008 - Apr 30, 2013
    Role: Principal Investigator
    Viral Mediated Type I Interferon Induction
    NIH R01AI069120Apr 1, 2006 - Feb 28, 2022
    Role: Principal Investigator
    Role of RIP2 in Biodefense Against Listeria Infection
    NIH R01AI052359May 15, 2004 - Apr 30, 2009
    Role: Principal Investigator
    Mechanisms of Biodefense by Toll-Like Receptors
    NIH R01AI056154Jul 1, 2003 - Apr 30, 2016
    Role: Principal Investigator
    The Apoptotic Role of MEKK1 in Cancer Chemotherapy
    NIH R01CA100241May 1, 2003 - Apr 30, 2008
    Role: Principal Investigator
    Using Genechips to Study the Immunological Roles of CD40
    NIH R01CA087924Apr 1, 2001 - Mar 31, 2006
    Role: Principal Investigator
    CD40 SIGNALING THROUGH TNF RECEPTOR ASSOCIATED FACTORS
    NIH R01GM057559Feb 1, 1999 - Jan 31, 2005
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses. Antimicrob Agents Chemother. 2019 Sep 16. Li C, Zu S, Deng YQ, Li D, Parvatiyar K, Quanquin N, Shang J, Sun N, Su J, Liu Z, Wang M, Aliyari SR, Li XF, Wu A, Ma F, Shi Y, Nielsevn-Saines K, Jung JU, Qin FX, Qin CF, Cheng G. PMID: 31527024.
      View in: PubMed   Mentions: 40     Fields:    
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-866-g4098221c on PROFILES-PWEB01.

    Copyright © The Regents of the University of California